Skip to content
KRM Ayurveda logo

KRM Ayurveda

KRMAYURVED NSE
₹231.10 No trade today
P/E
18.49
View as Markdown
MCP
Close 4 Nov 2026 ₹231.10 +50.40 +27.9% since 29 Jan 2026
Start ₹180.70

Key Fundamentals

SMEPharmaceuticals & BiotechnologyHealthcare

Price-based figures as of · TTM

ROCE
41.80%
Debt to Equity
0.68
EPS (TTM)
₹12.50
Book Value
₹53.95
Market Cap
—
P/E (TTM)
18.49
P/B
4.28
ROE
67.90%
Dividend Yield
0.00%
EBITDA
₹31.10 Cr
52W High
₹343.95
52W Low
₹156.15
Volume
0

Peer Comparison

Healthcare › Pharmaceuticals

KRM Ayurveda peer comparison
Sun Pharma
₹1,773.4038.81₹4,29,049 Cr4.770.90%16.00%20.50%₹61,631 Cr₹10,987 Cr
Divis Laboratories
₹10,037.5091.10₹2,65,269 Cr15.900.30%16.50%22.00%₹11,230 Cr₹2,925 Cr
Torrent Pharmaceuticals
₹4,738.5078.61₹1,77,061 Cr9.810.82%27.40%15.20%₹17,400 Cr₹2,099 Cr
Zydus Life Science
₹1,188.1026.44₹1,25,446 Cr4.370.08%21.20%21.10%₹28,592 Cr₹4,593 Cr
Laurus Labs
₹2,323.80114.81₹1,25,228 Cr20.720.04%18.30%17.80%₹7,270 Cr₹1,090 Cr
Dr Reddys Laboratories
₹1,374.0035.59₹1,14,543 Cr2.960.58%11.20%13.00%₹33,228 Cr₹3,184 Cr
Cipla
₹1,402.0033.59₹1,12,454 Cr3.200.93%11.60%15.50%₹28,324 Cr₹3,356 Cr
KRM Ayurveda (this company)
₹231.1018.49₹485 Cr4.280.00%67.90%41.80%₹110 Cr₹25 Cr
Median 8 companies₹1,587.7037.20₹1,25,337 Cr4.570.44%17.40%19.15%₹22,862 Cr₹3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1063
OscillatorsBullish243
Moving AveragesStrong Bearish820

Key readings

RSI (14)
35.32
Neutral
MACD (12,26,9)
−14.80
Bearish
SMA (50)
275.04
Bearish
SMA (200)
—
Neutral

As of

Growth Rate

From the financial statements below. 1Y: fiscal year to Mar 2025 against Mar 2024.

Revenue

Revenue growth by window
1Y+14.93%

Net profit

Net profit growth by window
1Y+300.00%

Operating cash flow

Operating cash flow growth by window
1YOutflow narrowed by ₹1 Cr

Operating margin· change in pp

Operating margin growth by window
1Y+12.74 pp

Trailing twelve months: The latest quarterly results are more than a year old.

Revenue by year

Revenue by year, ₹ crore
Mar 2023₹89.00 Cr
Mar 2024₹67.00 Cr
Mar 2025₹77.00 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2023₹8.00 Cr
Mar 2024₹3.00 Cr
Mar 2025₹12.00 Cr

Quarterly Results

₹ Cr

Results for the period ended Mar 2026 were due by 30 May 2026 and are not in this table yet.

760624 quarterly results, ₹ crore
Particulars Sep 2025
Sales
48
Expenses
36
Operating Profit
13
OPM %
27%
Other Income
0
Interest
2
Depreciation
1
PBT
11
Tax %
26%
Net Profit
8
EPS (₹)
5.24

Profit & Loss

₹ Cr
760624 profit and loss, annual, ₹ crore
Particulars Mar 2023Mar 2024Mar 2025
Sales
89
67
77
Expenses
78
60
57
Operating Profit
11
8
19
OPM %
13%
11%
25%
Other Income
0
0
0
Interest
1
2
2
Depreciation
1
1
1
PBT
10
5
16
Tax %
25%
28%
26%
Net Profit
8
3
12
EPS (₹)
5,067
2,273
807
Div. Payout %
0%
0%
0%

Balance Sheet

₹ Cr
760624 balance sheet, annual, ₹ crore
Particulars Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
0.15
0.15
0.15
16
Reserves
8
12
24
21
Borrowings
20
23
31
25
Other Liabilities
11
9
12
17
Total Liabilities
39
44
67
78
Fixed Assets
23
23
27
27
CWIP
0
0
0
0
Investments
0
0
0
0
Other Assets
16
21
40
52
Total Assets
39
44
67
78

Cash Flow

₹ Cr
760624 cash flow, annual, ₹ crore
Particulars Mar 2023Mar 2024Mar 2025
Operating
4
−1
0
Investing
−23
0
−4
Financing
19
1
6
Net Cash Flow
0
0
2

Ratios

760624 financial ratios, annual
Particulars Mar 2023Mar 2024Mar 2025
Debtor Days
32
30
58
Inventory Days
13
53
296
Days Payable
100
141
205
Cash Conversion Cycle
−55
−58
149
Working Capital Days
9
48
64
ROCE %
—
22%
42%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view KRM Ayurveda insights

28 extracted metrics across FY23–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 69.30%
  • Public 17.47%
  • Others 9.02%
  • DIIs 2.66%
  • FIIs 1.54%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about KRM Ayurveda

Where is KRM Ayurveda (KRMAYURVED) listed?
KRM Ayurveda trades as KRMAYURVED on the NSE.
Which sector does KRM Ayurveda belong to?
KRM Ayurveda is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the PE ratio of KRM Ayurveda?
KRM Ayurveda trades at a PE ratio of 18.49 as of 4 Nov 2026, on earnings per share of ₹12.5, against a book value of ₹53.95 per share.
What is the 52-week high and low of KRM Ayurveda?
Over the last 52 weeks KRM Ayurveda has traded between ₹156.15 and ₹343.95 as of 4 Nov 2026.
What is the Return on Equity (ROE) of KRM Ayurveda?
KRM Ayurveda reported a return on equity of 67.90%. Its debt-to-equity ratio is 0.68.

Company Information

Listed 29 Jan 2026

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/760624.md for KRM Ayurveda: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month